CN1057907C - 驱镉药物及其合成方法和应用 - Google Patents
驱镉药物及其合成方法和应用 Download PDFInfo
- Publication number
- CN1057907C CN1057907C CN95106341A CN95106341A CN1057907C CN 1057907 C CN1057907 C CN 1057907C CN 95106341 A CN95106341 A CN 95106341A CN 95106341 A CN95106341 A CN 95106341A CN 1057907 C CN1057907 C CN 1057907C
- Authority
- CN
- China
- Prior art keywords
- sodium
- cadmium
- hydroxy group
- group
- penta hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95106341A CN1057907C (zh) | 1995-06-13 | 1995-06-13 | 驱镉药物及其合成方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95106341A CN1057907C (zh) | 1995-06-13 | 1995-06-13 | 驱镉药物及其合成方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1137896A CN1137896A (zh) | 1996-12-18 |
CN1057907C true CN1057907C (zh) | 2000-11-01 |
Family
ID=5075879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95106341A Expired - Fee Related CN1057907C (zh) | 1995-06-13 | 1995-06-13 | 驱镉药物及其合成方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1057907C (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2658200A1 (en) * | 1998-07-06 | 2000-01-13 | Mgi Gp, Inc. | Naaladase inhibitors useful as pharmaceutical compounds and compositions |
CN100412082C (zh) * | 2003-10-16 | 2008-08-20 | 北京北医投资管理有限公司医药科技开发分公司 | 环糖基氨基酸及其制备方法和防治重金属中毒的用途 |
CN1884260B (zh) * | 2005-06-22 | 2010-11-10 | 广东省职业病防治院 | 一种化合物、其合成方法及其在制备驱除重金属和清除自由基药物中的应用 |
CN101077862B (zh) * | 2006-05-26 | 2011-04-20 | 首都医科大学 | D-葡萄糖基-l-氨基酸、其制备方法和应用 |
CN108276319B (zh) * | 2018-02-23 | 2019-11-12 | 广州同隽医药科技有限公司 | 一种硫代化合物及其应用 |
CN108546242B (zh) * | 2018-04-27 | 2019-11-12 | 广州同隽医药科技有限公司 | 一种氨基二硫代甲酸酯类化合物及其应用 |
CN109748834A (zh) * | 2018-10-11 | 2019-05-14 | 广东众尔健生物科技有限公司 | 一种金属配合物、制备方法及在重金属危害防治中的应用 |
-
1995
- 1995-06-13 CN CN95106341A patent/CN1057907C/zh not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
中国药理学报8(6) 1987.1.1 严雪铭等,奎胺酸对镉在动物体内分部和排泄的影响 * |
职业医学19(6) 1992.1.1 徐兆发等,甲氧苄基葡糖胺二硫代羧酸钠驱镉效果的实验研究 * |
职业医学19(6) 1992.1.1 徐兆发等,甲氧苄基葡糖胺二硫代羧酸钠驱镉效果的实验研究;中国药理学报8(6) 1987.1.1 严雪铭等,奎胺酸对镉在动物体内分部和排泄的影响 * |
Also Published As
Publication number | Publication date |
---|---|
CN1137896A (zh) | 1996-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Goldberg et al. | Experimentally produced porphyria in animals | |
JP3902406B2 (ja) | 老化防御効果を示すテトラペプチド、これを基にした薬理学的物質、及びその利用法 | |
CN1057907C (zh) | 驱镉药物及其合成方法和应用 | |
EP2987784A1 (de) | Verbesserung der bioverfügbarkeit von wirkstoffen mit amidinfunktion in arzneimitteln | |
JP2001503011A (ja) | ペプチドと、その合成方法と、それをベースにした医薬品 | |
CN1884260B (zh) | 一种化合物、其合成方法及其在制备驱除重金属和清除自由基药物中的应用 | |
JP6386550B2 (ja) | 血糖降下薬を調製するための瓦草五環系トリテルペノイドサポニン類化合物の使用 | |
CN1086289C (zh) | 大黄酸或大黄酸盐在制备治疗糖尿病肾病药中的用途 | |
CA1058186A (en) | L-pyroglutamyl-l-prolinamide | |
CN1872852A (zh) | 小檗碱衍生物及其制备方法和其药物组合物与用途 | |
FI92391C (fi) | Menetelmä 3-(N-fenyyliasetyyliaminopiperidiini)-2,6-dionin valmistamiseksi | |
CN112094322B (zh) | His-Gly-Lys修饰的甲氨蝶呤,其合成,抗肿瘤活性和应用 | |
CN112094320B (zh) | His-Gly-Glu修饰的甲氨蝶呤,其合成,抗肿瘤活性和应用 | |
CN1194705C (zh) | 天然蟾衣在制备一种治疗艾滋病中药中的应用 | |
CN1285340C (zh) | 多糖硫酸酯氨基酸盐类药物和制备方法及其应用 | |
CN1291721C (zh) | 蒜糖醇在制备糖尿病药物中的应用 | |
CN1240671C (zh) | N-(1-去氧葡萄糖醇-1-基)-氨基酸及其制备方法和用途 | |
CN1733717A (zh) | N,n’-二乙酰胱氨酸二精氨酸盐构型异构体及其用途 | |
WO2000054784A1 (en) | Complex comprising the coordination compound manganese, its medical effects and the mode of its production | |
CN115212288A (zh) | 酒精性肝损伤用化合物、制法、组合物、饮食品及用途 | |
CN1033856C (zh) | 具有中枢抑制作用的取代肉桂酸及其盐类衍生物 | |
CN1235599A (zh) | 新型联苯二甲酸衍生物及其制备方法 | |
RU2136303C1 (ru) | Способ получения средства для лечения ларвального и стробилярного эхинококкозов "чеблин ск-1" | |
Cuthbertson et al. | The effects of various chlorine derivatives of thyronine on serum cholesterol concentration and myocardial stimulation in rats and humans | |
CN101822662B (zh) | 9,10-二羟基硬脂酸(dhsa)在制备防治糖尿病药物中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: KANGZHE PHARMACEUTICAL INDUSTRY CO., LTD., SHENZH Free format text: FORMER OWNER: DEPARTMENT OF MEDICINE, PEKING UNIVERSITY Effective date: 20021025 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: DEPARTMENT OF MEDICINE, PEKING UNIVERSITY Free format text: FORMER NAME OR ADDRESS: BEIJING MEDICAL SCIENCE UNIV. |
|
CP01 | Change in the name or title of a patent holder |
Patentee after: BEIJING MEDICAL UNIC Patentee before: Beijing Medical University |
|
TR01 | Transfer of patent right |
Effective date of registration: 20021025 Address after: 518029, two floor, deep medicine building, three East Road, Bagua Road, Guangdong, Shenzhen Patentee after: CMS Peptides Patent Holding Co.,Ltd. Address before: 100083 No. 38, Haidian District, Beijing, Xueyuan Road Patentee before: BEIJING MEDICAL UNIC |
|
C56 | Change in the name or address of the patentee |
Owner name: DEPARTMENT OF MEDICINE, PEKING UNIVERSITY Free format text: FORMER NAME OR ADDRESS: BEIJING MEDICAL SCIENCE UNIV. |
|
CP01 | Change in the name or title of a patent holder |
Patentee after: BEIJING MEDICAL UNIC Patentee before: Beijing Medical University |
|
ASS | Succession or assignment of patent right |
Owner name: YITAI MEDICINE RESEARCH (SHENZHEN) CO., LTD. Free format text: FORMER OWNER: KANGZHE PHARMACEUTICAL INDUSTRY CO., LTD., SHENZHEN Effective date: 20030704 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20030704 Address after: Room three, deep medicine building, Bagua Road, Futian District, Shenzhen 301-304, China Patentee after: PEPHARM R & D LTD. Address before: Two floor, deep medicine building, three East Road, Bagua Road, Guangdong, Shenzhen Patentee before: CMS Peptides Patent Holding Co.,Ltd. |
|
C56 | Change in the name or address of the patentee |
Owner name: KANGZHE MEDICINE RESEARCH ( SHENZHEN ) CO., LTD. Free format text: FORMER NAME OR ADDRESS: YITAI MEDICINE RESEARCH (SHENZHEN) CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 518000, a bio incubator building in central high tech Zone, Shenzhen, 2-413 Patentee after: PEPHARM R & D LTD. Address before: 518029 Shenzhen Futian District Bagua three road deep medicine building, room 301-304 Patentee before: PEPHARM R & D LTD. |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20001101 Termination date: 20110613 |